Case ID: f-appx_157/html/0258-02.html
Source: Caselaw Access Project
Author: {"author": "", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

AVENTIS PHARMA S.A. and Aventis Pharmaceuticals, Inc., Plaintiffs-Appellants, v. AMPHASTAR PHARMACEUTICALS, INC., Defendant-Appellee, and Teva Pharmaceuticals USA, Inc., Defendant-Appellee. Aventis Pharma S.A. and Aventis Pharmaceuticals, Inc., Plaintiffs-Appellees, v. Amphastar Pharmaceuticals, Inc., Defendant-Appellant, and Teva Pharmaceuticals USA, Inc., Defendant.
    No. 05-1513, 05-1539.
    United States Court of Appeals, Federal Circuit.
    Nov. 1, 2005.
   ORDER

Aventis Pharma S.A. et al. (Aventis) move to dismiss Amphastar Pharmaceuticals, Inc.’s appeal, 05-1539, of a claim construction ruling in Aventis Pharma S. A v. Amphastar Pharmaceuticals, Inc., 03-CV-887 (C.D.Cal. Oct. 21, 2004). Amphastar does not oppose.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) Aventis’ unopposed motion to dismiss Amphastar’s appeal, 05-1539, is granted.

(2) All sides shall bear their own costs for 05-1539. 
      
       We note that Amphastar states that it "does not oppose Aventis’ Motion in so far as it seeks to dismiss Amphastar’s Cross-Appeal without prejudice.” However, it is not the practice of this court to dismiss with or without prejudice.